Cocoa Flavanols and Exercise Capacity

Sponsor
Heinrich-Heine University, Duesseldorf (Other)
Overall Status
Completed
CT.gov ID
NCT01259739
Collaborator
(none)
13
1
2
36
0.4

Study Details

Study Description

Brief Summary

The purpose of this study is to characterize the potential improvement of cocoa flavanols on exercise capacity in highly trained cyclist. A placebo-controlled double-blinded randomized control study will be performed in 13 highly trained cyclist (crossover design). Participants will perform a baseline exercise testing on an ergometer. They will receive either a flavanol-poor or flavanol rich cocoa drink twice daily for one week before a second and third exercise testing is performed. The order of drinks is randomized and balanced (high-flavanol-->low-flavanol drink or low-flavanol drink-->high-flavanol drink)

Condition or Disease Intervention/Treatment Phase
  • Other: Cocoa
N/A

Detailed Description

13 participants (highly-trained cyclist, accustomed to exercise testing on ergometers will be enrolled (VO2max>50 ml/kg, FMD >5%, non-smokers, no medication, no diseases, age 20-36, male).

Baseline Testing:

Participants will perform a baseline testing consisting of an ergometric test with a step-wise increase of workload until exhaustion to determine lactate anaerobic threshold and cardio-pulmonary exercise capacity. Vascular function is monitored by Doppler Ultrasound.

In a second test, participants will perform a time trial (goal: as fast as possible)

Flavanol intervention Participants will twice daily receive either a flavanol-poor cocoa drink (13mg/dl)or a flavanol-rich cocoa drink (596mg/dl) over a period of 7 days. Order is randomized and balanced. Subjects will crossover to the second arm after a washout period of 7 days.

Testing performed on baseline day is repeated after the intake of both drinks

In a subgroup of n=6 participants, we will test whether the blood pressure cuff maneuver used for FMD will itself modify nitrite levels. For this the manuever will be completed 4 times and compared to n=6 untreated controls. in another subgroup 6 participants will receive 4times the maneuver but reperfusion will be limited by means of an ultrasound probe.

Study Design

Study Type:
Interventional
Actual Enrollment :
13 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose:
Basic Science
Official Title:
The Impact of Dietary Cocoa Flavanols on Cardio-pulmonary Exercise Capacity in Human.
Study Start Date :
Nov 1, 2010
Actual Primary Completion Date :
Oct 1, 2013
Actual Study Completion Date :
Nov 1, 2013

Arms and Interventions

Arm Intervention/Treatment
Experimental: Flavanol rich cocoa

(596 mg), dissolved in water, twice daily intervention

Other: Cocoa
dissolved in water twice-daily intervention

Experimental: flavanol poor cocoa drink

( 13mg) dissolved in water, twice daily intervention

Other: Cocoa
dissolved in water twice-daily intervention

Outcome Measures

Primary Outcome Measures

  1. Cardiopulmonary exercise capacity (time to complete time trail, lactate anaerobic threshold, cardio-pulmonary exercise capacity [7 days]

Secondary Outcome Measures

  1. Endothelial function [7 days]

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 36 Years
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • highly trained cyclists (VO2 peak > 50 ml/kg bodyweight)

  • refrain from cocoa ingestion during trial

  • training continued throughout testing

  • 20 years

  • male

Exclusion Criteria:
  • 36 years

  • poor endothelial function

  • acute infection

  • any chronic heart or pulmonary disease

  • arrhythmias

  • acute or chronic renal failure

  • smokers

  • cardio-vascular risk factors : diabetes mellitus, hypertension, hyperlipidemia

  • intake of nutrition supplements (l-arginine, creatinine)

  • intake of WADA listed doping substances

Contacts and Locations

Locations

Site City State Country Postal Code
1 Heinrich-Heine-University Duesseldorf NRW Germany 40225

Sponsors and Collaborators

  • Heinrich-Heine University, Duesseldorf

Investigators

  • Principal Investigator: Tienush Rassaf, MD, PhD, Heinrich Heine University Düsseldorf, NRW, Germany
  • Study Chair: Malte Kelm, MD, PhD, Heinrich Heine University Düsseldorf, NRW, Germany

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
Klinik für Kardiologie, Pneumologie und Angiologie, Tienush Rassaf, MD, PhD, Heinrich-Heine University, Duesseldorf
ClinicalTrials.gov Identifier:
NCT01259739
Other Study ID Numbers:
  • Flavanols - Exercise
First Posted:
Dec 14, 2010
Last Update Posted:
Nov 8, 2013
Last Verified:
Nov 1, 2013
Keywords provided by Klinik für Kardiologie, Pneumologie und Angiologie, Tienush Rassaf, MD, PhD, Heinrich-Heine University, Duesseldorf

Study Results

No Results Posted as of Nov 8, 2013